222 related articles for article (PubMed ID: 29573741)
1. HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia.
Sarnelli G; Seguella L; Pesce M; Lu J; Gigli S; Bruzzese E; Lattanzi R; D'Alessandro A; Cuomo R; Steardo L; Esposito G
J Neuroinflammation; 2018 Mar; 15(1):94. PubMed ID: 29573741
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
3. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system.
Esposito G; Capoccia E; Gigli S; Pesce M; Bruzzese E; D'Alessandro A; Cirillo C; di Cerbo A; Cuomo R; Seguella L; Steardo L; Sarnelli G
Sci Rep; 2017 Aug; 7(1):7735. PubMed ID: 28798420
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic signaling in the gut: a novel mechanism of barrier protection through activation of enteric glia cells.
Cheadle GA; Costantini TW; Bansal V; Eliceiri BP; Coimbra R
Surg Infect (Larchmt); 2014 Aug; 15(4):387-93. PubMed ID: 24828283
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO.
Di Paola R; Cordaro M; Crupi R; Siracusa R; Campolo M; Bruschetta G; Fusco R; Pugliatti P; Esposito E; Cuzzocrea S
Shock; 2016 Aug; 46(2):202-13. PubMed ID: 26844976
[TBL] [Abstract][Full Text] [Related]
8.
Li M; Wang D; Bi W; Jiang ZE; Piao R; Yu H
J Pharmacol Exp Ther; 2019 Apr; 369(1):163-172. PubMed ID: 30635472
[No Abstract] [Full Text] [Related]
9. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
Esposito E; Impellizzeri D; Mazzon E; Paterniti I; Cuzzocrea S
PLoS One; 2012; 7(8):e41880. PubMed ID: 22912680
[TBL] [Abstract][Full Text] [Related]
11. Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia.
Sarnelli G; Pesce M; Seguella L; Lu J; Efficie E; Tack J; Elisa De Palma FD; D'Alessandro A; Esposito G
Cell Mol Gastroenterol Hepatol; 2021; 11(3):841-855. PubMed ID: 33065341
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
[TBL] [Abstract][Full Text] [Related]
13. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system.
Guedia J; Brun P; Bhave S; Fitting S; Kang M; Dewey WL; Hauser KF; Akbarali HI
Sci Rep; 2016 Aug; 6():31203. PubMed ID: 27491828
[TBL] [Abstract][Full Text] [Related]
15. Pyridostigmine bromide exposure creates chronic, underlying neuroimmune disruption in the gastrointestinal tract and brain that alters responses to palmitoylethanolamide in a mouse model of Gulf War Illness.
Hernandez S; Morales-Soto W; Grubišić V; Fried D; Gulbransen BD
Neuropharmacology; 2020 Nov; 179():108264. PubMed ID: 32758565
[TBL] [Abstract][Full Text] [Related]
16. Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse.
Lapierre J; Rodriguez M; Ojha CR; El-Hage N
J Neuroimmune Pharmacol; 2018 Sep; 13(3):355-370. PubMed ID: 29752681
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
[TBL] [Abstract][Full Text] [Related]
18. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
[TBL] [Abstract][Full Text] [Related]
19. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart.
Razeghi P; Wang ME; Youker KA; Golfman L; Stepkowski S; Taegtmeyer H
Cardiovasc Res; 2007 Apr; 74(1):133-9. PubMed ID: 17276423
[TBL] [Abstract][Full Text] [Related]
20. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
